P412: Efficacy and safety of additional autologous platelet-rich stroma in transanal mucosal advancement flap repair of complex cryptoglandular anal fistulas
ECCO '19 Copenhagen
2019
P413: A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn’s disease
ECCO '19 Copenhagen
2019
P414: Ustekinumab endoscopic response at Week 16 is associated with early normalisation of faecal calprotectin after induction
ECCO '19 Copenhagen
2019
P415: Predictive factors of a subsequent ano-perineal abscess in patients with fistulising ano-perineal Crohn’s disease in remission
ECCO '19 Copenhagen
2019
P416: Faecal calprotectin can predict mucosal healing in patients with inflammatory bowel diseases treated with vedolizumab: a prospective single-centre study
ECCO '19 Copenhagen
2019
P417: 10 years of endoscopic therapy of symptomatic Crohn’s disease stenoses: a retrospective analysis of long-term results
ECCO '19 Copenhagen
2019
P418: Safety and efficacy of olorinab, a peripherally restricted, highly-selective, cannabinoid receptor 2 agonist in a phase 2A study in chronic abdominal pain associated with Crohn’s disease
ECCO '19 Copenhagen
2019
P420: Correlation between Infliximab trough levels and endoscopic activity in ulcerative colitis
ECCO '19 Copenhagen
2019
P421: Effects of combination therapy in inflammatory bowel disease: how long should we keep concomitant immunomodulators?
ECCO '19 Copenhagen
2019
P422: Immunogenicity of a proposed adalimumab biosimilar, FKB327, and the reference product in patients with rheumatoid arthritis
ECCO '19 Copenhagen
2019
P423: Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis
ECCO '19 Copenhagen
2019
P424: Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multi-centre cohort study of the ENEIDA registry
ECCO '19 Copenhagen
2019
P425: Development of an enzyme-linked immunosorbent assay for therapeutic drug monitoring of ustekinumab
ECCO '19 Copenhagen
2019
P426: Lympocytosis in patients with inflammatory bowel disease treated with anti-TNFa agents: is it significant?
ECCO '19 Copenhagen
2019
P427: Impact of curcuma longa on clinical activity and inflammatory markers in patients with active ulcerative colitis: a double-blind randomised placebo-controlled trial
ECCO '19 Copenhagen
2019
P428: Long-term outcomes of endoscopic ballon dilation for small-bowl strictures using double balloon enteroscopy in patients with Crohn’s disease
ECCO '19 Copenhagen
2019